The latest from across eye care — curated by B-Seen
Big data commonly are characterized by the 3 Vs: volume, variety, and velocity.1 Big data enable the recognition of complex patterns across diverse data types and sources, particularly when combined with artificial intelligence techniques, often leading to novel hypotheses and insights. As a result, the rise of big data has transformed health care research, especially in ophthalmology, where electronic health records (EHRs) and imaging are routinely collected from clinical practice, and big data resources can be leveraged for scientific discovery.
The application of artificial intelligence (AI) in age-related macular degeneration (AMD) screening has been limited by the absence of a standardized reference framework. Unlike diabetic retinopathy, where well-established grading systems have enabled regulatory approval and widespread deployment of autonomous AI, AMD remains characterized by classification systems, imaging interpretation, and referral thresholds. This lack of uniformity introduces challenges in defining ground truth, limits reproducibility across studies, and complicates regulatory evaluation.
EssilorLuxottica and Applied Materials, Inc. announced a long-term joint development agreement to accelerate the commercialization of next-generation intelligent optical systems for augmented reality and AI-powered smart eyewear. The collaboration combines EssilorLuxottica’s global leadership in lenses, frames and smart eyewear with Applied Materials’ expertise in materials engineering and waveguide technologies.
A bill allowing optometrists in Vermont to perform certain laser procedures, injections and surgical procedures has been signed into law. Vermont is now the 17th state to include laser surgery in optometrists’ scope of practice, following the addition of Tennessee in April. The bill was signed into law by Gov. Phil Scott on June 18 and takes effect in July 2028, according to a press release from the American Optometric Association. “It has been a tremendous amount of work by advocates of the profession who care about Vermonters’ access to high-quality eye care,” Dean Barcelow, OD,
A 93-year-old woman presented with sequential bilateral decreased vision within 2 weeks. Symptoms initially began in the right eye and were characterized by intermittent perception of a blue ribbon and missing letters while reading and distortion of straight lines. Two weeks later, she presented with new insidious, painless vision loss in the left eye. Her ocular history was significant for cataract extraction with posterior chamber IOL placement in the right eye 5 years prior, bilateral primary open-angle glaucoma managed by a glaucoma specialist and previously known age-related macular
The historical paradigm of cataract surgery forced an absolute compromise: pristine distance vision with absolute spectacle dependence or an expanded range of vision at the cost of contrast sensitivity and night dysphotopsia. Today, next-generation nondiffractive designs are shifting those boundaries, reshaping how we counsel patients and tailor premium visual outcomes. For decades, premium cataract surgery was defined by a structured, often rigid trade-off matrix. When patients expressed a desire for spectacle independence, our clinical algorithms immediately pivoted to a discussion of
Last year, HHS and dozens of health insurers announced an industry pledge to streamline and reduce prior authorization. According to America’s Health Insurance Plans (AHIP), that pledge has led to an 11% reduction in prior authorizations “across a range of medical services,” leading to 6.5 million fewer prior authorizations. AHIP also announced that health insurers participating in the pledge will standardize the process for submitting electronic prior authorization requests for most services, including imaging services like CT scans and MRIs and orthopedic surgeries. These services span
PHOENIX—The American Optometric Association (AOA) closed out a landmark Optometry’s Meeting in Phoenix with the election of its 2026-2027 board of trustees and the installation of Teri K. Geist, OD, of Nebraska, as the 106th president of the AOA. Click here to view an exclusive video interview with Dr. Geist where she discusses advocacy, reimbursement and her top priorities as she takes the helm as AOA president. The profession’s premier annual event, which ran from June 17–20, was a record-setting event that brought together more than 6,000 attendees, including more than 3,000 students, residents, new doctors and faculty, the AOA said in an announcement.
MORRIS PLAINS, N.J.—Charmant Group and Lagardère Group, the owner of Elle, have announced the extension of their licensing agreement until 2031. The Charmant and Elle partnership was first signed in 1996, the companies said, and this extension renews the license for another five years. “Beyond being an icon of elegance and distinctive personal style, Elle also has a rich heritage and continues to define fashion and taste.” says Koji Horikawa, president and CEO of Charmant Group.
OBERKOCHEN, Germany—The Zeiss Group has reported slight revenue growth for the first half of its current fiscal year ending March 31, 2026, with revenue totaling €5.841 billion, up 1 percent from €5.794 billion reached in the same period the previous year. In making the announcement, Zeiss said “uncertainty in the global markets is still putting pressure” on its business, and that the segments’ “highly uneven development,” which was evident at the end of 2025, has continued. Earnings before interest and taxes (EBIT) amounted to €955 million, up €33 million euros from the prior-year period.
CHICAGO—The United Opticians Association’s (UOA) One Vision | One Voice | One UOA Leadership Conference begins this Thursday, June 25, and runs through June 27. Held at the Hilton Rosemont at O’Hare in Chicago, the three-day event will bring together hundreds of opticians, educators, advocates and more, the UOA said. Each day of the conference will focus on a different area of opticianry. According to the UOA, day 1 will focus on educators, innovators and explorers, including four hands-on labs with optician innovators to test tools, learn how to use new devices and more.
PARIS—Simple Eyewear, a minimalist Parisian optical and sunglass brand that says it designs for the “everyday wearer with simple tastes,” announced it has named The Frame Affair, as its exclusive U.S. distributor. The Frame Affair, a combined distribution agency and trade show, said this collaboration reinforces its role as a “strategic gateway for global independent eyewear brands entering the U.S. market, connecting visionary designers with the optical professionals shaping the future of the industry,” the announcement noted.
Riyadh, Saudi Arabia, will be the site of a major international gathering for the optometry and optical sectors from April 2 to 4, 2027, at the RICEC location. The event will bring together OptiVision Riyadh Saudi Arabia, the 6th World Congress of Optometry, SSO 2027 and SILMO Riyadh under the theme “One Vision. Global Future.”
PHOENIX — Screening healthy patients for glaucoma during routine eye exams led to glaucoma referrals that would not have been made otherwise, according to a prospective study presented at Optometry’s Meeting. Out of 104 patients, 13 were referred for further glaucoma evaluation, and one was diagnosed with active disease. The study was presented by Michael Chaglasian, OD, FAAO, of Illinois College of Optometry. During routine eye exams at Illinois Eye Institute, 104 patients aged 35 years or older were offered free spectral-domain OCT imaging using Maestro2 (Topcon Healthcare). The average age of
DENVER — A real-world analysis showed increased rates of undertreatment and attrition with anti-VEGF injections in patients with wet age-related macular degeneration over time, resulting in worse visual outcomes. According to a poster presented at the Association for Research in Vision and Ophthalmology meeting, the study aimed to address the knowledge gaps on the long-term impact of nonpersistence in anti-VEGF treatment on visual outcomes. “We performed a retrospective analysis of the Vestrum Health database to characterize the impact of a 6-month treatment gap in new wet AMD patients
JENA, Germany—Zeiss Medical Technology, a leader in medical optics and digital healthcare solutions, has announced a strategic collaboration with Envision Health Technologies, a digital eye health company founded by glaucoma surgeon Lama A. Al-Aswad, MD, MPH, CEO, to help advance glaucoma care through gamified virtual reality (VR) technology. The companies said this collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function testing, supported by Zeiss’ long history of innovation in perimetry, and will bring together clinical expertise and software innovation to help advance clinically relevant, patient-centered technologies for modern glaucoma care.
WASHINGTON, D.C.—In a historic win, Vermont became the 17th state to expand scope of practice for optometrists and improve access to essential eye healthcare services, with the authorization of optometric laser procedures. Signed by Vermont Gov. Phil Scott on June 18, the new law creates an Advanced Therapeutic Procedures Specialty License and, beginning July 1, 2028, authorizes qualified Vermont doctors of optometry to provide additional in-office procedures, including certain ophthalmic laser procedures, the American Optometric Association (AOA) said in an announcement.
LONDON—New research from Specsavers, the optical retail chain based in the United Kingdom, shows that 73 percent of adults in England feel the most anxious about eye treatment, more than any other body part, according to an announcement from the retailer. This fear, which Specsavers said is termed “eye anxiety,” can lead to delayed care for serious eye conditions including cataract, glaucoma and age-related macular degeneration (AMD). For this research, Specsavers commissioned a survey of 2,000 adults in England in April 2026.
PHOENIX—Optometry’s Meeting 2026 concluded this past weekend in Phoenix after a four-day schedule packed with special events and continuing education sessions. Serving as a hub for eyecare experts and students, the annual gathering brought together the profession's current leaders and its emerging talent to advance optometry and advocate for the field. This year’s program offered 300 hours of professional development and continuing education tailored for ODs and their staff, while an exhibit hall featuring over 150 vendors showcased the newest innovations in eyecare technology.
NEW YORK—SUNY College of Optometry has announced that a team of its faculty researchers led by Xiaoying Zhu, OD, Ph.D., MD, MS, FAAO, has been awarded a $500,000 Myopia Research Grant from the American Academy of Optometry Foundation (AAOF) and Meta Reality Labs Research, a specialized research division of Meta Platforms, Inc. that works with augmented reality (AR) and virtual reality (VR). The grant will fund the study of how children’s everyday visual experiences may contribute to the development and progression of myopia, according to the announcement.
To evaluate the association between cataract surgery (CS) and the risk of conversion from dry age-related macular degeneration (dAMD) to neovascular AMD (nvAMD), and to identify factors associated with conversion.
A 16-year-old boy presented after a BB gun injury to the left eye (OS). Best-corrected visual acuity (BCVA) was 20/100 in OS and 20/20 in the right eye. Slit-lamp examination showed conjunctival injection, circular corneal edema with Descemet folds at the impact site of the pellet, iritis, and microhyphema (A). Intraocular pressure and fundus examination were normal. At 1-week, corneal clarity improved after topical corticosteroids and cycloplegia, with BCVA of 20/20 (B). At 4 weeks, specular microscopy showed reduced endothelial cell density (ECD: 2020 vs.
A 25-year-old woman had sudden-onset vision loss and a visual acuity of 20/80 in the right eye while receiving hyaluronic acid-calcium hydroxylapatite (HA-CaHA) injection at the root of her nose during rhinoplasty. Funduscopy 14 days after the injection showed a pale optic nerve head (ONH) and diffuse pigment alteration of the peripheral nasal and inferior retina (A). Indocyanine green angiography revealed a filling defect in the nasal half of the choroid, normally perfused by the medial posterior ciliary artery that also supplies the optic nerve (B).
PHOENIX — Prescribing Qlosi eye drops for presbyopia was not associated with a reduction in optical purchases or other practice performance metrics, according to a study presented here. “The questions that kept coming up among our physicians were straightforward: Is this going to hurt us? Are patients going to stop buying glasses? Are we going to see fewer billable encounters?” Harmin J. Chima, OD, FAAO, vice president, professional services at West Point Optical Group, told Healio. “Those are legitimate questions, and nobody had real answers yet.” Orasis Pharmaceuticals worked with West Point
PHOENIX — Retaine Ultra PF, a preservative-free lubricating eye drop, is now available. The drop is an “economical option” intended for “rewetting and refreshing the eyes,” Jacob Shorrosh, marketing associate at OcuSoft, told Healio at Optometry’s Meeting. “This is going to be for an aqueous-deficient patient,” Shorrosh said. “It’s not going to target any lipid deficiency, which [meibomian gland dysfunction] patients have. It’s more for patients who need that aqueous refreshment to the tear film.” The drop comes in a 10 mL multidose bottle, and the active ingredients are polyethylene glycol 400
LAS VEGAS — Ocula360, an AI-based tool for diabetic retinopathy lesion detection, showed efficacy in detecting DR across multiple levels of severity, according to a speaker at Clinical Trials at the Summit. While several automated DR assessment tools have been FDA approved, there are limitations in screening for disease severity, SriniVas R. Sadda, MD, of Doheny Eye Institute, said. “In the ideal world, we would actually automatically detect all of the lesions on these ultra-widefield images, and that could potentially facilitate a quantitative and continuous scoring system for diabetic
PHOENIX — Mirvetuximab, an antibody drug conjugate for the treatment of certain types of cancer, can lead to adverse ocular events in the early weeks of treatment, according to a poster here. Across four cases of folate receptor-alpha positive, platinum-resistant epithelial ovarian and fallopian tube cancer, three patients developed corneal subepithelial microcysts in the early weeks of treatment with Elahere (mirvetuximab, AbbVie). Other findings included superficial punctate keratitis, epithelial ridge, stromal haze and posterior subcapsular cataract. “For most, the initial presentation was in
Training, circular economy and CSE certification: ANFAO vice president for ESG sustainability Michele Gasparini discusses the initiatives supporting eyewear companies in adopting increasingly responsible and strategic business models. Gasparini said, “Over the past few years, we have seen growing interest from companies in sustainability-related topics.”
Recent data suggest that 85% of dry eye disease in the U.S. is partially or completely evaporative dry eye. This means that 85% of dry eye disease (DED) likely originates in the meibomian glands of affected patients. Now is as good a time as any to review best practices for evaluating and treating meibomian gland dysfunction (MGD). But first we should look at the proper way to arrive at whatever we might call “best practices.” In a recent post on my “new look” Healio blog, I offered some thoughts on what “real” science might be. We live in an era in which there is a seemingly overwhelming urge
Recent data suggest that 85% of dry eye disease in the U.S. is partially or completely evaporative dry eye. This means that 85% of dry eye disease (DED) likely originates in the meibomian glands of affected patients. Now is as good a time as any to review best practices for evaluating and treating meibomian gland dysfunction (MGD). But first we should look at the proper way to arrive at whatever we might call “best practices.” In a recent post on my “new look” Healio blog, I offered some thoughts on what “real” science might be. We live in an era in which there is a seemingly overwhelming urge
PHOENIX—Teri K. Geist, OD, president-elect of the American Optometric Association (AOA), is slated to be sworn in as the organization's president today, Saturday, June 20, during the association’s House of Delegates gathering at Optometry’s Meeting in Phoenix. Earlier this week and ahead of her installation, Vision Monday spoke with Dr. Geist, who joined the AOA Board of Trustees in 2019 and was appointed president-elect in 2025, about her priorities and the major issues facing the profession. In an exclusive interview with VM’s senior editor Daniel Breeman, she said she plans to build on the momentum the association has already made in advancing optometry’s role as a primary eyecare profession.
PHOENIX—Arizona Optometric Association president Jon Beeson, OD, officially kicked off Optometry’s Meeting 2026 on Wednesday night by welcoming attendees to this year’s event and the city of Phoenix. Following Dr. Beeson’s welcoming remarks, current AOA president Jacquie M. Bowen, OD, took the stage and expressed her enthusiasm for this year’s event that has attracted more than 3,000 students, residents, new doctors and faculty joining the more than 5,500 attendees. “Patients need us now more than ever,” Dr. Bowen said. “Patients are looking for answers. Patients are struggling to access care. It’s the eye exam with us that is the gateway to the broader health arena and a better picture for our patients.”
ALEXANDRIA, Va.—During a June 15 webinar, The Vision Council reviewed the fast-moving tariff landscape for optical importers and urged its members to move quickly on refund claims tied to the now-invalidated tariffs that were issued under the International Emergency Economic Powers Act (IEEPA), as well as prepare for a possible wave of new duties later this summer. Rick Van Arnam, regulatory affairs counsel for The Vision Council, led the webinar, offering insight into the refund process, the potential government appeal, updates on Section 122 duties and the looming Section 301 duties expected to be enacted in July.
COLUMBIA, Md.—The Foundation Fighting Blindness, a private funding source for retinal degenerative disease research and its venture arm, the RD Fund (Retinal Degeneration Fund), have announced a $1 million commitment from A Race Against Blindness (RAB) to advance gene-agnostic therapeutic approaches for inherited retinal diseases. The commitment includes $775,000 for the RD Fund and $225,000 for a Foundation Fighting Blindness research award. The $775,000 contribution to the RD Fund will be matched dollar for dollar through the Gordon and Llura Gund Foundation Challenge, unlocking a total of $1.55 million in funding. The challenge doubles all new and increased gifts to the RD Fund, according to the announcement.
AREQUIPA, Peru—Global eyecare nonprofit Orbis International announced it has launched a two-week ophthalmic training project in Arequipa, Peru, aboard the Orbis Flying Eye Hospital, the world's only fully accredited ophthalmic teaching hospital on an aircraft. Orbis said the project was launched at the request of Peru's Ministry of Health and in partnership with Hospital Regional Honorio Delgado Espinoza. The initiative aims to expand access to high-quality eyecare and training across southern Peru, including in rural and Indigenous communities, the announcement noted.
Vermont becomes the 17th state to authorize optometric laser procedures—and the third state in 2026 to modernize optometric practice.
A 68-year-old man presented with a mass at the right canthus for >30 years. Examination revealed a yellowish-white, firm, mobile tumor on the right caruncle, with defined borders. The surface was irregular with abundant blood supply (A). Pathological and immunohistochemical examination confirmed a sebaceous adenoma of the caruncle. Hematoxylin-eosin staining revealed polygonal tumor cells arranged in nests. Central tumor cells displayed foamy cytoplasm (asterisks), with well-defined sebaceous lobules of varying sizes and shapes (B).
PHOENIX — David L. Parker, OD, an optometric practice owner and former state senator in Mississippi, was named optometrist of the year at Optometry’s Meeting. Other winners of AOA Excellence Awards included Douglas Morrow, OD, who received the Distinguished Service Award, and the nonprofit group iSee Ohio, which received the Apollo Award for distinguished service to the visual welfare of the public. Parker told Healio he was “deeply honored” to be named optometrist of the year. He is the owner of Olive Branch Eyecare and Horn Lake Eyecare in Mississippi and served as a Mississippi state senator
WASHINGTON — Cyclodialysis performed with modern ab interno approaches should not be discounted as a treatment option for glaucoma, according to a speaker. “The original surgery was abandoned when trabeculectomy and glaucoma drainage devices came in, in part because the results were not always predictable,” Robert L. Stamper, MD, ABO, told Healio at the American Society of Cataract and Refractive surgery meeting. “But with newer techniques — perhaps going from ab interno using structures or materials to keep the cyclodialysis cleft open — I think we may be able to get more reproducible
PHOENIX — Patients diagnosed with retinal venous malformations should always undergo additional imaging to rule out microvascular or cerebral changes, according to a poster here. “Retinal venous malformations are an abnormal vessel, typically a vein, which crosses the horizontal raphe and passes through the macula,” Brittney Brady, OD, FAAO, associate professor at Illinois College of Optometry, told Healio. “While considered benign and likely underreported, vision loss secondary to retinal venous malformations may occur. ... More importantly, patients with retinal venous malformations have a
PHOENIX — Infuse for Astigmatism lenses were comfortable and provided consistently clear vision throughout the day in patients who had dryness with their habitual lenses, according to a study presented at Optometry’s Meeting. “Astigmatism patients have traditionally been the ones who are most cognizant of their lenses, the reason being that the lenses are typically larger, and they typically need to be balanced on the eye,” Mile Brujic, OD, FAAO, who practices at Premier Vision Group in Ohio and is a consultant for Bausch + Lomb, told Healio. “So, Bausch + Lomb essentially said, ‘All right,
On Saturday, June 20, more than 75 athletes and avid cyclists will be gearing up and riding together from Vaughan to Alliston and Collingwood, Ontario, for EyeRide 2026. The third-annual cycling event raises vital funds for three small-but-mighty organizations: TRAILBLAZERS Tandem Cycling Club, BALANCE for Blind Adults and Blind Sailing Association of Canada.
Click here to read the Healio Exclusive, “Rising rate of ocular allergies calls for collaborative, eco-conscious interventions.” The most common forms of ocular allergy are seasonal allergic conjunctivitis and perennial allergic conjunctivitis. They can be annoying and negatively affect quality of life but are not sight-threatening. Both are ocular hypersensitivity disorders caused by exposure to an allergen trigger and mediated by immunoglobulin E. Seasonal allergic conjunctivitis (SAC) is worse for most in the spring and fall, and perennial allergic conjunctivitis (PAC) lasts all year long.
Click here to read the Healio Exclusive, “Rising rate of ocular allergies calls for collaborative, eco-conscious interventions.” The most common forms of ocular allergy are seasonal allergic conjunctivitis and perennial allergic conjunctivitis. They can be annoying and negatively affect quality of life but are not sight-threatening. Both are ocular hypersensitivity disorders caused by exposure to an allergen trigger and mediated by immunoglobulin E. Seasonal allergic conjunctivitis (SAC) is worse for most in the spring and fall, and perennial allergic conjunctivitis (PAC) lasts all year long.
Big data commonly are characterized by the 3 Vs: volume, variety, and velocity.1 Big data enable the recognition of complex patterns across diverse data types and sources, particularly when combined with artificial intelligence techniques, often leading to novel hypotheses and insights. As a result, the rise of big data has transformed health care research, especially in ophthalmology, where electronic health records (EHRs) and imaging are routinely collected from clinical practice, and big data resources can be leveraged for scientific discovery.
The application of artificial intelligence (AI) in age-related macular degeneration (AMD) screening has been limited by the absence of a standardized reference framework. Unlike diabetic retinopathy, where well-established grading systems have enabled regulatory approval and widespread deployment of autonomous AI, AMD remains characterized by classification systems, imaging interpretation, and referral thresholds. This lack of uniformity introduces challenges in defining ground truth, limits reproducibility across studies, and complicates regulatory evaluation.
EssilorLuxottica and Applied Materials, Inc. announced a long-term joint development agreement to accelerate the commercialization of next-generation intelligent optical systems for augmented reality and AI-powered smart eyewear. The collaboration combines EssilorLuxottica’s global leadership in lenses, frames and smart eyewear with Applied Materials’ expertise in materials engineering and waveguide technologies.
A bill allowing optometrists in Vermont to perform certain laser procedures, injections and surgical procedures has been signed into law. Vermont is now the 17th state to include laser surgery in optometrists’ scope of practice, following the addition of Tennessee in April. The bill was signed into law by Gov. Phil Scott on June 18 and takes effect in July 2028, according to a press release from the American Optometric Association. “It has been a tremendous amount of work by advocates of the profession who care about Vermonters’ access to high-quality eye care,” Dean Barcelow, OD,
A 93-year-old woman presented with sequential bilateral decreased vision within 2 weeks. Symptoms initially began in the right eye and were characterized by intermittent perception of a blue ribbon and missing letters while reading and distortion of straight lines. Two weeks later, she presented with new insidious, painless vision loss in the left eye. Her ocular history was significant for cataract extraction with posterior chamber IOL placement in the right eye 5 years prior, bilateral primary open-angle glaucoma managed by a glaucoma specialist and previously known age-related macular
The historical paradigm of cataract surgery forced an absolute compromise: pristine distance vision with absolute spectacle dependence or an expanded range of vision at the cost of contrast sensitivity and night dysphotopsia. Today, next-generation nondiffractive designs are shifting those boundaries, reshaping how we counsel patients and tailor premium visual outcomes. For decades, premium cataract surgery was defined by a structured, often rigid trade-off matrix. When patients expressed a desire for spectacle independence, our clinical algorithms immediately pivoted to a discussion of
Last year, HHS and dozens of health insurers announced an industry pledge to streamline and reduce prior authorization. According to America’s Health Insurance Plans (AHIP), that pledge has led to an 11% reduction in prior authorizations “across a range of medical services,” leading to 6.5 million fewer prior authorizations. AHIP also announced that health insurers participating in the pledge will standardize the process for submitting electronic prior authorization requests for most services, including imaging services like CT scans and MRIs and orthopedic surgeries. These services span
PHOENIX—The American Optometric Association (AOA) closed out a landmark Optometry’s Meeting in Phoenix with the election of its 2026-2027 board of trustees and the installation of Teri K. Geist, OD, of Nebraska, as the 106th president of the AOA. Click here to view an exclusive video interview with Dr. Geist where she discusses advocacy, reimbursement and her top priorities as she takes the helm as AOA president. The profession’s premier annual event, which ran from June 17–20, was a record-setting event that brought together more than 6,000 attendees, including more than 3,000 students, residents, new doctors and faculty, the AOA said in an announcement.
MORRIS PLAINS, N.J.—Charmant Group and Lagardère Group, the owner of Elle, have announced the extension of their licensing agreement until 2031. The Charmant and Elle partnership was first signed in 1996, the companies said, and this extension renews the license for another five years. “Beyond being an icon of elegance and distinctive personal style, Elle also has a rich heritage and continues to define fashion and taste.” says Koji Horikawa, president and CEO of Charmant Group.
OBERKOCHEN, Germany—The Zeiss Group has reported slight revenue growth for the first half of its current fiscal year ending March 31, 2026, with revenue totaling €5.841 billion, up 1 percent from €5.794 billion reached in the same period the previous year. In making the announcement, Zeiss said “uncertainty in the global markets is still putting pressure” on its business, and that the segments’ “highly uneven development,” which was evident at the end of 2025, has continued. Earnings before interest and taxes (EBIT) amounted to €955 million, up €33 million euros from the prior-year period.
CHICAGO—The United Opticians Association’s (UOA) One Vision | One Voice | One UOA Leadership Conference begins this Thursday, June 25, and runs through June 27. Held at the Hilton Rosemont at O’Hare in Chicago, the three-day event will bring together hundreds of opticians, educators, advocates and more, the UOA said. Each day of the conference will focus on a different area of opticianry. According to the UOA, day 1 will focus on educators, innovators and explorers, including four hands-on labs with optician innovators to test tools, learn how to use new devices and more.
PARIS—Simple Eyewear, a minimalist Parisian optical and sunglass brand that says it designs for the “everyday wearer with simple tastes,” announced it has named The Frame Affair, as its exclusive U.S. distributor. The Frame Affair, a combined distribution agency and trade show, said this collaboration reinforces its role as a “strategic gateway for global independent eyewear brands entering the U.S. market, connecting visionary designers with the optical professionals shaping the future of the industry,” the announcement noted.
Riyadh, Saudi Arabia, will be the site of a major international gathering for the optometry and optical sectors from April 2 to 4, 2027, at the RICEC location. The event will bring together OptiVision Riyadh Saudi Arabia, the 6th World Congress of Optometry, SSO 2027 and SILMO Riyadh under the theme “One Vision. Global Future.”
PHOENIX — Screening healthy patients for glaucoma during routine eye exams led to glaucoma referrals that would not have been made otherwise, according to a prospective study presented at Optometry’s Meeting. Out of 104 patients, 13 were referred for further glaucoma evaluation, and one was diagnosed with active disease. The study was presented by Michael Chaglasian, OD, FAAO, of Illinois College of Optometry. During routine eye exams at Illinois Eye Institute, 104 patients aged 35 years or older were offered free spectral-domain OCT imaging using Maestro2 (Topcon Healthcare). The average age of
DENVER — A real-world analysis showed increased rates of undertreatment and attrition with anti-VEGF injections in patients with wet age-related macular degeneration over time, resulting in worse visual outcomes. According to a poster presented at the Association for Research in Vision and Ophthalmology meeting, the study aimed to address the knowledge gaps on the long-term impact of nonpersistence in anti-VEGF treatment on visual outcomes. “We performed a retrospective analysis of the Vestrum Health database to characterize the impact of a 6-month treatment gap in new wet AMD patients
JENA, Germany—Zeiss Medical Technology, a leader in medical optics and digital healthcare solutions, has announced a strategic collaboration with Envision Health Technologies, a digital eye health company founded by glaucoma surgeon Lama A. Al-Aswad, MD, MPH, CEO, to help advance glaucoma care through gamified virtual reality (VR) technology. The companies said this collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function testing, supported by Zeiss’ long history of innovation in perimetry, and will bring together clinical expertise and software innovation to help advance clinically relevant, patient-centered technologies for modern glaucoma care.
WASHINGTON, D.C.—In a historic win, Vermont became the 17th state to expand scope of practice for optometrists and improve access to essential eye healthcare services, with the authorization of optometric laser procedures. Signed by Vermont Gov. Phil Scott on June 18, the new law creates an Advanced Therapeutic Procedures Specialty License and, beginning July 1, 2028, authorizes qualified Vermont doctors of optometry to provide additional in-office procedures, including certain ophthalmic laser procedures, the American Optometric Association (AOA) said in an announcement.
LONDON—New research from Specsavers, the optical retail chain based in the United Kingdom, shows that 73 percent of adults in England feel the most anxious about eye treatment, more than any other body part, according to an announcement from the retailer. This fear, which Specsavers said is termed “eye anxiety,” can lead to delayed care for serious eye conditions including cataract, glaucoma and age-related macular degeneration (AMD). For this research, Specsavers commissioned a survey of 2,000 adults in England in April 2026.
PHOENIX—Optometry’s Meeting 2026 concluded this past weekend in Phoenix after a four-day schedule packed with special events and continuing education sessions. Serving as a hub for eyecare experts and students, the annual gathering brought together the profession's current leaders and its emerging talent to advance optometry and advocate for the field. This year’s program offered 300 hours of professional development and continuing education tailored for ODs and their staff, while an exhibit hall featuring over 150 vendors showcased the newest innovations in eyecare technology.
NEW YORK—SUNY College of Optometry has announced that a team of its faculty researchers led by Xiaoying Zhu, OD, Ph.D., MD, MS, FAAO, has been awarded a $500,000 Myopia Research Grant from the American Academy of Optometry Foundation (AAOF) and Meta Reality Labs Research, a specialized research division of Meta Platforms, Inc. that works with augmented reality (AR) and virtual reality (VR). The grant will fund the study of how children’s everyday visual experiences may contribute to the development and progression of myopia, according to the announcement.
To evaluate the association between cataract surgery (CS) and the risk of conversion from dry age-related macular degeneration (dAMD) to neovascular AMD (nvAMD), and to identify factors associated with conversion.
A 16-year-old boy presented after a BB gun injury to the left eye (OS). Best-corrected visual acuity (BCVA) was 20/100 in OS and 20/20 in the right eye. Slit-lamp examination showed conjunctival injection, circular corneal edema with Descemet folds at the impact site of the pellet, iritis, and microhyphema (A). Intraocular pressure and fundus examination were normal. At 1-week, corneal clarity improved after topical corticosteroids and cycloplegia, with BCVA of 20/20 (B). At 4 weeks, specular microscopy showed reduced endothelial cell density (ECD: 2020 vs.
A 25-year-old woman had sudden-onset vision loss and a visual acuity of 20/80 in the right eye while receiving hyaluronic acid-calcium hydroxylapatite (HA-CaHA) injection at the root of her nose during rhinoplasty. Funduscopy 14 days after the injection showed a pale optic nerve head (ONH) and diffuse pigment alteration of the peripheral nasal and inferior retina (A). Indocyanine green angiography revealed a filling defect in the nasal half of the choroid, normally perfused by the medial posterior ciliary artery that also supplies the optic nerve (B).
PHOENIX — Prescribing Qlosi eye drops for presbyopia was not associated with a reduction in optical purchases or other practice performance metrics, according to a study presented here. “The questions that kept coming up among our physicians were straightforward: Is this going to hurt us? Are patients going to stop buying glasses? Are we going to see fewer billable encounters?” Harmin J. Chima, OD, FAAO, vice president, professional services at West Point Optical Group, told Healio. “Those are legitimate questions, and nobody had real answers yet.” Orasis Pharmaceuticals worked with West Point
PHOENIX — Retaine Ultra PF, a preservative-free lubricating eye drop, is now available. The drop is an “economical option” intended for “rewetting and refreshing the eyes,” Jacob Shorrosh, marketing associate at OcuSoft, told Healio at Optometry’s Meeting. “This is going to be for an aqueous-deficient patient,” Shorrosh said. “It’s not going to target any lipid deficiency, which [meibomian gland dysfunction] patients have. It’s more for patients who need that aqueous refreshment to the tear film.” The drop comes in a 10 mL multidose bottle, and the active ingredients are polyethylene glycol 400
LAS VEGAS — Ocula360, an AI-based tool for diabetic retinopathy lesion detection, showed efficacy in detecting DR across multiple levels of severity, according to a speaker at Clinical Trials at the Summit. While several automated DR assessment tools have been FDA approved, there are limitations in screening for disease severity, SriniVas R. Sadda, MD, of Doheny Eye Institute, said. “In the ideal world, we would actually automatically detect all of the lesions on these ultra-widefield images, and that could potentially facilitate a quantitative and continuous scoring system for diabetic
PHOENIX — Mirvetuximab, an antibody drug conjugate for the treatment of certain types of cancer, can lead to adverse ocular events in the early weeks of treatment, according to a poster here. Across four cases of folate receptor-alpha positive, platinum-resistant epithelial ovarian and fallopian tube cancer, three patients developed corneal subepithelial microcysts in the early weeks of treatment with Elahere (mirvetuximab, AbbVie). Other findings included superficial punctate keratitis, epithelial ridge, stromal haze and posterior subcapsular cataract. “For most, the initial presentation was in
Training, circular economy and CSE certification: ANFAO vice president for ESG sustainability Michele Gasparini discusses the initiatives supporting eyewear companies in adopting increasingly responsible and strategic business models. Gasparini said, “Over the past few years, we have seen growing interest from companies in sustainability-related topics.”
Recent data suggest that 85% of dry eye disease in the U.S. is partially or completely evaporative dry eye. This means that 85% of dry eye disease (DED) likely originates in the meibomian glands of affected patients. Now is as good a time as any to review best practices for evaluating and treating meibomian gland dysfunction (MGD). But first we should look at the proper way to arrive at whatever we might call “best practices.” In a recent post on my “new look” Healio blog, I offered some thoughts on what “real” science might be. We live in an era in which there is a seemingly overwhelming urge
Recent data suggest that 85% of dry eye disease in the U.S. is partially or completely evaporative dry eye. This means that 85% of dry eye disease (DED) likely originates in the meibomian glands of affected patients. Now is as good a time as any to review best practices for evaluating and treating meibomian gland dysfunction (MGD). But first we should look at the proper way to arrive at whatever we might call “best practices.” In a recent post on my “new look” Healio blog, I offered some thoughts on what “real” science might be. We live in an era in which there is a seemingly overwhelming urge
PHOENIX—Teri K. Geist, OD, president-elect of the American Optometric Association (AOA), is slated to be sworn in as the organization's president today, Saturday, June 20, during the association’s House of Delegates gathering at Optometry’s Meeting in Phoenix. Earlier this week and ahead of her installation, Vision Monday spoke with Dr. Geist, who joined the AOA Board of Trustees in 2019 and was appointed president-elect in 2025, about her priorities and the major issues facing the profession. In an exclusive interview with VM’s senior editor Daniel Breeman, she said she plans to build on the momentum the association has already made in advancing optometry’s role as a primary eyecare profession.
PHOENIX—Arizona Optometric Association president Jon Beeson, OD, officially kicked off Optometry’s Meeting 2026 on Wednesday night by welcoming attendees to this year’s event and the city of Phoenix. Following Dr. Beeson’s welcoming remarks, current AOA president Jacquie M. Bowen, OD, took the stage and expressed her enthusiasm for this year’s event that has attracted more than 3,000 students, residents, new doctors and faculty joining the more than 5,500 attendees. “Patients need us now more than ever,” Dr. Bowen said. “Patients are looking for answers. Patients are struggling to access care. It’s the eye exam with us that is the gateway to the broader health arena and a better picture for our patients.”
ALEXANDRIA, Va.—During a June 15 webinar, The Vision Council reviewed the fast-moving tariff landscape for optical importers and urged its members to move quickly on refund claims tied to the now-invalidated tariffs that were issued under the International Emergency Economic Powers Act (IEEPA), as well as prepare for a possible wave of new duties later this summer. Rick Van Arnam, regulatory affairs counsel for The Vision Council, led the webinar, offering insight into the refund process, the potential government appeal, updates on Section 122 duties and the looming Section 301 duties expected to be enacted in July.
COLUMBIA, Md.—The Foundation Fighting Blindness, a private funding source for retinal degenerative disease research and its venture arm, the RD Fund (Retinal Degeneration Fund), have announced a $1 million commitment from A Race Against Blindness (RAB) to advance gene-agnostic therapeutic approaches for inherited retinal diseases. The commitment includes $775,000 for the RD Fund and $225,000 for a Foundation Fighting Blindness research award. The $775,000 contribution to the RD Fund will be matched dollar for dollar through the Gordon and Llura Gund Foundation Challenge, unlocking a total of $1.55 million in funding. The challenge doubles all new and increased gifts to the RD Fund, according to the announcement.
AREQUIPA, Peru—Global eyecare nonprofit Orbis International announced it has launched a two-week ophthalmic training project in Arequipa, Peru, aboard the Orbis Flying Eye Hospital, the world's only fully accredited ophthalmic teaching hospital on an aircraft. Orbis said the project was launched at the request of Peru's Ministry of Health and in partnership with Hospital Regional Honorio Delgado Espinoza. The initiative aims to expand access to high-quality eyecare and training across southern Peru, including in rural and Indigenous communities, the announcement noted.
Vermont becomes the 17th state to authorize optometric laser procedures—and the third state in 2026 to modernize optometric practice.
A 68-year-old man presented with a mass at the right canthus for >30 years. Examination revealed a yellowish-white, firm, mobile tumor on the right caruncle, with defined borders. The surface was irregular with abundant blood supply (A). Pathological and immunohistochemical examination confirmed a sebaceous adenoma of the caruncle. Hematoxylin-eosin staining revealed polygonal tumor cells arranged in nests. Central tumor cells displayed foamy cytoplasm (asterisks), with well-defined sebaceous lobules of varying sizes and shapes (B).
PHOENIX — David L. Parker, OD, an optometric practice owner and former state senator in Mississippi, was named optometrist of the year at Optometry’s Meeting. Other winners of AOA Excellence Awards included Douglas Morrow, OD, who received the Distinguished Service Award, and the nonprofit group iSee Ohio, which received the Apollo Award for distinguished service to the visual welfare of the public. Parker told Healio he was “deeply honored” to be named optometrist of the year. He is the owner of Olive Branch Eyecare and Horn Lake Eyecare in Mississippi and served as a Mississippi state senator
WASHINGTON — Cyclodialysis performed with modern ab interno approaches should not be discounted as a treatment option for glaucoma, according to a speaker. “The original surgery was abandoned when trabeculectomy and glaucoma drainage devices came in, in part because the results were not always predictable,” Robert L. Stamper, MD, ABO, told Healio at the American Society of Cataract and Refractive surgery meeting. “But with newer techniques — perhaps going from ab interno using structures or materials to keep the cyclodialysis cleft open — I think we may be able to get more reproducible
PHOENIX — Patients diagnosed with retinal venous malformations should always undergo additional imaging to rule out microvascular or cerebral changes, according to a poster here. “Retinal venous malformations are an abnormal vessel, typically a vein, which crosses the horizontal raphe and passes through the macula,” Brittney Brady, OD, FAAO, associate professor at Illinois College of Optometry, told Healio. “While considered benign and likely underreported, vision loss secondary to retinal venous malformations may occur. ... More importantly, patients with retinal venous malformations have a
PHOENIX — Infuse for Astigmatism lenses were comfortable and provided consistently clear vision throughout the day in patients who had dryness with their habitual lenses, according to a study presented at Optometry’s Meeting. “Astigmatism patients have traditionally been the ones who are most cognizant of their lenses, the reason being that the lenses are typically larger, and they typically need to be balanced on the eye,” Mile Brujic, OD, FAAO, who practices at Premier Vision Group in Ohio and is a consultant for Bausch + Lomb, told Healio. “So, Bausch + Lomb essentially said, ‘All right,
On Saturday, June 20, more than 75 athletes and avid cyclists will be gearing up and riding together from Vaughan to Alliston and Collingwood, Ontario, for EyeRide 2026. The third-annual cycling event raises vital funds for three small-but-mighty organizations: TRAILBLAZERS Tandem Cycling Club, BALANCE for Blind Adults and Blind Sailing Association of Canada.
Click here to read the Healio Exclusive, “Rising rate of ocular allergies calls for collaborative, eco-conscious interventions.” The most common forms of ocular allergy are seasonal allergic conjunctivitis and perennial allergic conjunctivitis. They can be annoying and negatively affect quality of life but are not sight-threatening. Both are ocular hypersensitivity disorders caused by exposure to an allergen trigger and mediated by immunoglobulin E. Seasonal allergic conjunctivitis (SAC) is worse for most in the spring and fall, and perennial allergic conjunctivitis (PAC) lasts all year long.
Click here to read the Healio Exclusive, “Rising rate of ocular allergies calls for collaborative, eco-conscious interventions.” The most common forms of ocular allergy are seasonal allergic conjunctivitis and perennial allergic conjunctivitis. They can be annoying and negatively affect quality of life but are not sight-threatening. Both are ocular hypersensitivity disorders caused by exposure to an allergen trigger and mediated by immunoglobulin E. Seasonal allergic conjunctivitis (SAC) is worse for most in the spring and fall, and perennial allergic conjunctivitis (PAC) lasts all year long.
B-Seen aggregates headlines from leading eye care publications. All content belongs to its respective publishers. Want your publication featured or removed? Contact us.
